Luke M. Shelton

A Novel Hypokalemic-Alkalotic Salt-Losing Tubulopathy in Patients with CLDN10 Mutations

Ernie M.H.F. Bongers, Luke M. Shelton, Susanne Milatz et al. · Journal of the American Society of Nephrology · 2017 · 61 citations · Full text

Residual biomasses and protein hydrolysates of three green microalgae species exhibit antioxidant and anti-aging activity

Claudia D. Norzagaray-Valenzuela, Ángel Valdez-Ortíz, Luke M. Shelton et al. · Journal of Applied Phycology · 2016 · 58 citations

Algal Biomass, Bioenergy, Algal Cultivation +7

Thematic Review Series: Sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a

P Mukherjee, Anthony C. Faber, Luke M. Shelton et al. · Journal of Lipid Research · 2008 · 53 citations · Full text

Ganglioside Gm3, Vascular Disease, Angiogenesis +8

Integrated transcriptomic and proteomic analyses uncover regulatory roles of Nrf2 in the kidney

Luke M. Shelton, Adam Lister, Joanne Walsh et al. · Kidney International · 2015 · 52 citations · Full text

Reductive Stress, Transcriptional Regulation, Renal Function +12

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Chris Parker, Noel W. Clarke, Adrian Cook et al. · The Lancet · 2024 · 43 citations · Full text